Versant Capital Management’s Anavex Life Sciences AVXL Stock Holding History

Versant Capital Management’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-417	Closed	-$1.28K	–	2758
2026 Q1	$1.28K	Buy	+417	New	+$1.81K	﹤0.01%	2625
2025 Q4	–	Sell	-1,484	Closed	-$13.2K	–	2652
2025 Q3	$13.2K	Hold	1,484	–	–	﹤0.01%	1806
2025 Q2	$13.7K	Hold	1,484	–	–	﹤0.01%	1736
2025 Q1	$12.7K	Hold	1,484	–	–	﹤0.01%	1597
2024 Q4	$15.9K	Buy	+1,484	New	+$11.4K	﹤0.01%	1145

Other funds holding AVXL

PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

Sheets Smith Wealth Management Winston-Salem, North Carolina $1B AUM 29.77% 1-Year Est. Return

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return